Viewing Study NCT02750592


Ignite Creation Date: 2025-12-24 @ 3:32 PM
Ignite Modification Date: 2026-01-29 @ 1:43 PM
Study NCT ID: NCT02750592
Status: COMPLETED
Last Update Posted: 2019-09-09
First Post: 2016-04-04
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-03-22
Start Date Type: ACTUAL
Primary Completion Date: 2017-07-05
Primary Completion Date Type: ACTUAL
Completion Date: 2018-05-16
Completion Date Type: ACTUAL
First Submit Date: 2016-04-04
First Submit QC Date: None
Study First Post Date: 2016-04-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-05-14
Results First Submit QC Date: None
Results First Post Date: 2019-09-09
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-08-02
Last Update Post Date: 2019-09-09
Last Update Post Date Type: ACTUAL